Literature DB >> 14553965

Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice.

Atsushi Ueda1, Ryoji Ozono, Tetsuya Oshima, Ai Yano, Masayuki Kambe, Yasuhiro Teranishi, Motoya Katsuki, Kazuaki Chayama.   

Abstract

BACKGROUND: Dopamine D(2) receptors (D(2)Rs) are expressed in the kidney. It has not been determined whether D(2)Rs are involved in the mechanism of sodium handling and blood pressure (BP) control.
METHODS: The function of D(2)Rs was investigated in mice disrupted with D(2)R gene (D(2)KO mice). Six-week-old male D(2)KO mice and wild-type (WT) mice were fed high-salt (4% NaCl) or low-salt (0.01% NaCl) diets for 8 weeks.
RESULTS: Before starting the metabolic diet, there were no significant differences in body weight, food consumption, and 24-h urine excretions of creatinine, sodium and potassium. The high-salt diet caused a significant elevation in systolic BP in D(2)KO mice but not in WT mice. Calculation of sodium and potassium balances revealed a significantly high level of sodium retention in D(2)KO mice placed on the high-salt diet. Twenty-four-hour urine norepinephrine excretions and heart rates, indicators of sympathetic activity, were not different in D(2)KO and WT mice on the high-salt diet. Administration of nemonapride, a specific D(2)-like receptor antagonist, to WT mice given 0.9% NaCl in drinking water caused suppression of urinary sodium excretion but had no effect in mice without salt loading.
CONCLUSIONS: These results suggest that D(2) receptors promote sodium excretion during a period of high salt intake. A defect in this mechanism may result in sodium-dependent BP elevation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14553965     DOI: 10.1016/s0895-7061(03)01013-6

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  19 in total

Review 1.  Potential dopamine-1 receptor stimulation in hypertension management.

Authors:  Mohammad Asghar; Seyed K Tayebati; Mustafa F Lokhandwala; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

Review 2.  Genetics of salt-sensitive hypertension.

Authors:  Hironobu Sanada; John E Jones; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

3.  Dopamine D₁-like receptors regulate the α₁A-adrenergic receptor in human renal proximal tubule cells and D₁-like dopamine receptor knockout mice.

Authors:  Riley Charles Ennis; Laureano D Asico; Ines Armando; Jian Yang; Jun B Feranil; Julie A Jurgens; Crisanto S Escano; Peiying Yu; Xiaoyan Wang; David R Sibley; Pedro A Jose; Van Anthony M Villar
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-22

4.  Acute regulation of renal Na+/H+ exchanger NHE3 by dopamine: role of protein phosphatase 2A.

Authors:  I Alexandru Bobulescu; Henry Quiñones; Serge M Gisler; Francesca Di Sole; Ming-Chang Hu; Mingjun Shi; Jianning Zhang; Daniel G Fuster; Nancy Wright; Marc Mumby; Orson W Moe
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-24

Review 5.  The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.

Authors:  Ines Armando; Prasad Konkalmatt; Robin A Felder; Pedro A Jose
Journal:  Transl Res       Date:  2014-07-25       Impact factor: 7.012

6.  Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase.

Authors:  Yu Yang; Yanrong Zhang; Santiago Cuevas; Van Anthony Villar; Crisanto Escano; Laureano D Asico; Peiying Yu; David K Grandy; Robin A Felder; Ines Armando; Pedro A Jose
Journal:  Free Radic Biol Med       Date:  2012-05-23       Impact factor: 7.376

7.  D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1.

Authors:  Quansheng Lu; Yu Yang; Van Anthony Villar; Laureano Asico; John E Jones; Peiying Yu; Hewang Li; Edward J Weinman; Gilbert M Eisner; Pedro A Jose
Journal:  Hypertens Res       Date:  2013-02-21       Impact factor: 3.872

Review 8.  Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice.

Authors:  Xiaoyan Wang; Van Anthony M Villar; Ines Armando; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Pediatr Nephrol       Date:  2008-07-10       Impact factor: 3.714

9.  Direct inhibition of basolateral Kir4.1/5.1 and Kir4.1 channels in the cortical collecting duct by dopamine.

Authors:  Oleg L Zaika; Mykola Mamenko; Oleg Palygin; Nabila Boukelmoune; Alexander Staruschenko; Oleh Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-28

10.  Dopamine D3 receptor inhibits the ubiquitin-specific peptidase 48 to promote NHE3 degradation.

Authors:  Ines Armando; Van Anthony M Villar; John E Jones; Hewang Lee; Xiaoyan Wang; Laureano D Asico; Peiying Yu; Jian Yang; Crisanto S Escano; Annabelle M Pascua-Crusan; Robin A Felder; Pedro A Jose
Journal:  FASEB J       Date:  2013-12-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.